Department of Cancer Biology
Animals; Autocrine Communication; Carcinoma; Colonic Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Integrin alpha5; Integrin beta Chains; Intestinal Mucosa; Mesoderm; Mice; Mice, Nude; Neoplasm Invasiveness; Prognosis; Transcription, Genetic; Transforming Growth Factor beta; Tumor Markers, Biological
Cancer Biology | Neoplasms
We used a spheroid model of colon carcinoma to analyze integrin dynamics as a function of the epithelial-mesenchymal transition (EMT), a process that provides a paradigm for understanding how carcinoma cells acquire a more aggressive phenotype. This EMT involves transcriptional activation of the beta6 integrin subunit and a consequent induction of alphavbeta6 expression. This integrin enhances the tumorigenic properties of colon carcinoma, including activation of autocrine TGF-beta and migration on interstitial fibronectin. Importantly, this study validates the clinical relevance of the EMT. Kaplan-Meier analysis of beta6 expression in 488 colorectal carcinomas revealed a striking reduction in median survival time of patients with high beta6 expression. Elevated receptor expression did not simply reflect increasing tumor stage, since log-rank analysis showed a more significant impact on the survival of patients with early-stage, as opposed to late-stage, disease. Cox regression analysis confirmed that this integrin is an independent variable for these tumors. These findings define the alphavbeta6 integrin as an important risk factor for early-stage disease and a novel therapeutic candidate for colorectal cancer.
DOI of Published Version
J Clin Invest. 2005 Feb;115(2):339-47. Link to article on publisher's site
The Journal of clinical investigation
Bates, Richard C.; Bellovin, David I.; Brown, Courtney; Maynard, Elizabeth; Wu, Bingyan; Kawakatsu, Hisaaki; Sheppard, Dean; Oettgen, Peter; and Mercurio, Arthur M., "Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma" (2005). Cancer Biology Publications and Presentations. 179.